Lysophosphatidylcholine transduces Ca2+ signaling via the platelet- activating factor receptor in macrophages

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 272, Issue 1 41-1, 1997, Pages

  Ogita, Teruhiko ^b   Tanaka, Yuji ^b   Nakaoka, Takashi ^a   Matsuoka, Rumiko ^b   Kira, Yuji ^b   Nakamura, Motonao ^b   Shimizu, Takao ^b   Fujita, Toshiro ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b NONE

Author keywords

atherosclerosis; cholesterol; inflammation; lactate dehydrogenase; lysolecithin

Indexed keywords

CALCIUM ION; LYSOPHOSPHATIDYLCHOLINE; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; ANTITHROMBOCYTIC AGENT; APAFANT; AZEPINE DERIVATIVE; CALCIUM; CELL SURFACE RECEPTOR; CHOLESTEROL; FIBRINOGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; LACTATE DEHYDROGENASE; TRIAZOLE DERIVATIVE;

ANIMAL CELL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CALCIUM CELL LEVEL; CHO CELL; CONTROLLED STUDY; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; DRUG EFFECT; FEMALE; GENETIC TRANSFECTION; GENETICS; HAMSTER; INSTITUTE FOR CANCER RESEARCH MOUSE; INTRACELLULAR MEMBRANE; METABOLISM; OSMOLARITY; PHYSIOLOGY;

ANIMALS; AZEPINES; CALCIUM; CHO CELLS; CHOLESTEROL; CRICETINAE; FEMALE; INTRACELLULAR MEMBRANES; L-LACTATE DEHYDROGENASE; LYSOPHOSPHATIDYLCHOLINES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED ICR; OSMOLAR CONCENTRATION; PLATELET AGGREGATION INHIBITORS; PLATELET MEMBRANE GLYCOPROTEINS; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; TRANSFECTION; TRIAZOLES;

EID: 0031031935     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1997.272.1.h17     Document Type: Article

References (12)

1. Adams, D. O. Effector mechanisms of cytolytically activated macrophages. J. Immunol. 124: 286-292, 1985.
2. Aoki, Y., M. Nakamura, H. Kodama, T. Matsumoto, T. Shimizu, and M. Noma. A radioreceptor binding assay for platelet-activating factor (PAF) using membranes from CHO cells expressing human PAF receptor. J. Immunol. Methods 186: 225-231, 1995.
3. Casals-Stenzel, J., G. Muacevic, and K. H. Weber. Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor. J. Pharmacol. Exp. Ther. 241: 974-981, 1987.
4. Conforto, A., R. Dudek, M. R. Hoffmann, and R. J. Bing. The production of nitric oxide in endothelial cells by amphiphiles. Life Sci. 54: 1143-1153, 1994.
5. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260: 3440-3450, 1985.
6. Heather, F. M., S. Parthasarathy, and D. Steinberg. Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes. J. Clin. Invest. 92: 1004-1008, 1993.
7. Hirayama, T., Y. Ogawa, K. Tobise, and S. Onodera. Mechanism of endothelium-dependent vasorelaxation to lysophosphatidylcholine (Abstract). Jpn. J. Pharmacol. 58: 391, 1992.
8. Honda, Z., T. Takano, Y. Gotoh, E. Nishida, K. Ito, and T. Shimizu. Transfected platelet-activating factor receptor activates mitogen-activated protein (MAP) kinase and MAP kinase kinase in Chinese hamster ovary cells. J. Biol. Chem. 269: 2307-2315, 1994.
9. Kugiyama, K., S. A. Kerns, J. D. Morrisett, R. Roberts, and P. D. Henry. Impairment of endothelium-dependent relaxation by lysolecithin in modified low-density lipoproteins. Nature Lond. 344: 160-162, 1990.
10. Kume, N., M. I. Cybulsky, and M. A. Gimbrone, Jr. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J. Clin. Invest. 90: 1138-1144, 1992.
11. Kume, N., and M. A. Gimbrone, Jr. Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J. Clin. Invest. 93: 907-911, 1994.
12. Nakamura, M., Z. Honda, T. Izumi, C. Sakanaka, H. Mutoh, M. Minami, H. Bito, Y. Seyama, T. Matsumoto, M. Noma, and T. Shimizu. Molecular cloning and expression of platelet-activating factor receptor from human leukocytes. J. Biol. Chem. 266: 20400-20405, 1991.